Pfizer Inc. (PFE)
3 High-Yield Dividends That Pay You Soon (But You Must Act Quickly)
Income investors watching the calendar have a narrow window this week. Three of the market's most widely held high-yield names are about to lock their next payment rosters, and the buy-by deadlines are close enough that a delayed brokerage order could push readers a full quarter down the line before the next check clears.
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Pfizer or AstraZeneca: Which Stock Offers Better Long-Term Potential?
AZN targets continued 2026 growth with expanding blockbuster medicines, a strong pipeline and 2030 revenue goals as it outpaces Pfizer on key metrics.
Pfizer (PFE) Stock Sinks As Market Gains: Here's Why
Pfizer (PFE) concluded the recent trading session at $23.72, signifying a -2.47% move from its prior day's close.
Pfizer (PFE) Stock Declines While Market Improves: Some Information for Investors
Pfizer (PFE) closed at $24.08 in the latest trading session, marking a -1.19% move from the prior day.
Wall Street Walked Away From This Powerhouse Stock, But I Am Buying It on Repeat
I keep buying Pfizer (NYSE:PFE | PFE Price Prediction) every time my brokerage cash builds up, and I am not slowing down.
This 7% Yielding Healthcare Powerhouse Belongs in Retirees' Portfolios
Few large-cap dividends generate as much skepticism as Pfizer (NYSE:PFE | PFE Price Prediction).
Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review
Pfizer's GLP-1 drug Ecnoglutide and Innovent Biologics' mazdutide injection have passed a preliminary review to be potentially included in China's basic medical insurance drug catalogue, a a list published by the National Healthcare Security Administration showed on Monday.
Opinion: Pfizer Is a Fantastic Dividend Stock for Income Investors to Buy Right Now
Pfizer is one of the world's largest drug companies. It has a long history of navigating the industry's ups and downs.
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Pfizer (PFE) Falls More Steeply Than Broader Market: What Investors Need to Know
In the most recent trading session, Pfizer (PFE) closed at $24.04, indicating a -2.75% shift from the previous trading day.
Nike names former Pfizer CFO David Denton as finance chief
Nike Inc (NYSE:NKE, XETRA:NKE) has announced that David Denton will join the company as executive vice president and chief financial officer effective August 17, succeeding Matthew Friend, who will remain with the company through September 4 to support the transition. According to the company, Denton will lead Nike's global finance organization and work alongside president and CEO Elliott Hill and the senior leadership team on capital allocation, financial discipline and long-term growth initiatives.
